About CARE™

The CARE™ (Community. Academic. Research. Education.) Faculty is a national group of specialists from across Canada.

We develop education initiatives directed at our peers, as well as to nurses, pharmacists, patients, government and payers. CARE™ programs have been successfully run in oncology, hematology, gastroenterology, infectious disease, neuromuscular, pathology and respirology.


Our Current Events

Recent Publications

The CARE™ ACG/UEGW 2019 Conference Report highlights key news in gastroenterology with a specific focus on inflammatory bowel disease (IBD), framed from a Canadian perspective.

View Publication




CARE™ Perspectives:



CARE™ Perspectives:

ESMO 2019

2018 and 2019 have seen numerous data updates and news that could affect the management of prostate cancer (PC) in Canada. The following CARE™ Conference Report from ESMO 2019 focuses on prostate cancer updates.

View Publication

CARE™ Faculty recently spoke with CLL expert, Dr. Paolo Ghia (Milan, Italy) to get a global perspective on these advances and how they have impacted his practice.

View Publication


CARE™ Global Interview Series:

Management of CLL in the Current Landscape


CARE™ Update:

Highlights from iwCLL 2019 & CARE™ CLL Treatment Guidance

Members of the CARE™ Faculty recently met at the International Workshop on CLL (iwCLL 2019, September 20th-23rd in Edinburgh, Scotland) to review the latest data and news. A review of key plenary themes from the iwCLL meeting has been provided by CARE™ Faculty who attended.

View Publication


Darolutamide approved for nonmetastatic castration-resistant prostate cancer. https://t.co/UjPoIYuq5j #HarvardHealth

CARE™ at ASH is NEXT WEEK! This event provides hematologists, residents, fellows, and junior faculty across Canada a unique opportunity to gather, discuss and address relevant issues in hematology.

Register while you still can: https://t.co/dXwwh2tpR3

Load More...


Forum on Complement Case Series

This 4-part series sheds light on challenges many Paroxysmal Nocturnal Hemoglobinuria (PNH) patients encounter during their disease course.